The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) Center for Tobacco Products to foster tobacco regulatory research.
With funds from the FDA, NIH can provide new funding opportunities in tobacco regulatory science that complement existing NIH tobacco research activities.
- RFA-OD-23-021: Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
- RFA-OD-23-017: Tobacco Regulatory Science (R01 Clinical Trial Optional)
- NOT-OD-23-078: Notice of Information for RFA-OD-21-003
- NOT-OD-23-079: Notice of Information for RFA-OD-21-004
NIH and FDA are pleased to announce the recent awarding of eight new Center grants.
The Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL 2.0) in Tobacco Regulatory Science is the coordination and dissemination hub for all CTP-funded extramural research at the NIH. New to CASEL 2.0 is an Opportunity Fund that will solicit rapid-response projects from the extramural community to address FDA CTP’s high priority, time-sensitive research needs.
Additionally, seven institutions have been awarded a third cohort of the multidisciplinary Tobacco Centers of Regulatory Science (TCORS 3.0), a long-standing component of the TRSP. Scientists with a broad range of expertise (e.g., epidemiology, economics, toxicology, addiction, and marketing), will generate critical research to inform the FDA’s regulation of tobacco products.
An NIH-FDA partnership to foster tobacco regulatory research.
Tobacco regulatory research projects funded through TRSP.
Active funding opportunities and application information.
Research topic and project priorities for TRSP funding opportunities.
Research tools, publications, statistics, and announcements.